Relating to: a sales and use tax exemption for the sale of over-the-counter drugs. (FE)

This bill would exempt over-the-counter drugs from state sales and use taxes. It directly affects consumers purchasing non-prescription medications and retailers selling these products. The legislation defines over-the-counter drugs as those with specific labeling requirements, including a drug facts panel or a list of active ingredients. By removing the tax burden, the bill aims to lower costs for buyers of these common health products. The change would take effect on the first day of the third month after the bill is published.